[31-419-am] Drug information 2/Formulation testing 2

Sun. Mar 31, 2024 8:30 AM - 9:30 AM [Room 419] Conference Center 419 (4F)

Chair: Hiroshi Miyata, Kazuo Takayama

+Add all to schedule

8:30 AM - 8:42 AM

[31-419-am01S] Comparison of Adverse Event Profiles of Amphotericin B and Liposomal Amphotericin B Formulations in the real world

○Yuka Nokura¹, Mika Maezawa², Satoshi Nakao², Wataru Wakabayashi¹, Sakiko Hirofuji¹, Koumi Miyasaka¹, Nanaka Ichihara¹, Moe Yamashita¹, Kensuke Matsui¹, Kohei Tahara^1,2, Mitsuhiro Nakamura^1,2 (1. Gifu Pharmaceutical Univ., 2. Grad. Sch. Pharm. Sci. , Gifu Pharmaceutical Univ.)

8:42 AM - 8:54 AM

[31-419-am02S] Analysis of acute generalized exanthematous pustulosis using the Japanese Adverse Drug Event Report database

○Moe Yamashita¹, Mika Maezawa², Wataru Wakabayashi¹, Sakiko Hirofuji¹, Koumi Miyasaka¹, Nanaka Ichihara¹, Yuka Nokura¹, Kensuke Matsui¹, Satoshi Nakao^2,3, Hiroyuki Tanaka^1,2, Mitsuhiro Nakamura^1,2 (1. Gifu Pharmaceutical Univ., 2. Grad. Sch. Pharm. Sci., Gifu Pharmaceutical Univ., 3. Kyushu Univ. Hosp.)

8:54 AM - 9:06 AM

[31-419-am03S] Analysis of metformin-associated lactic acidosis using Japanese Adverse Drug Event Report database

○Nanaka Ichihara¹, Mika Maezawa², Satoshi Nakao^2,3, Koumi Miyasaka¹, Sakiko Hirofuji¹, Moe Yamashita¹, Yuka Nokura¹, Kensuke Matsui¹, Mayumi Kitamura⁴, Megumi Horibe⁴, Kazuhiro Iguchi^1,2, Mitsuhiro Nakamura^1,2 (1. Gifu Pharmaceutical Univ., 2. Grad. Sch. Sci., Gifu Pharmaceutical Univ., 3. Kyushu Univ. Hosp., 4. Asahi Univ.)

9:06 AM - 9:18 AM

[31-419-am04S] Examining the importance of paper abstract element selection in implementing an automatic literature review model for updating systematic reviews using machine learning

○Tatsuki Hasegawa, Shuntaro Yada², Hayato Kizaki¹, Shungo Imai¹, Eiji Aramaki², Satoko Hori¹ (1. Keio univ. Pharm., 2. NAIST)

9:18 AM - 9:30 AM

[31-419-am05S] Reducing adhesion to administration devices during pediatric doses of Ethyl Icosapentate by simple suspension method via enteral feeding catheter

○Joe Teshima¹, Emi Yamaguchi², Shigeo Akiyama³, Shiro Ishida¹ (1. Kagawa Sch. Pharm. Scie., Tokushima Bunri Univ., 2. Dep. Pharm., Sendai Med. Center, 3. Fac. Pharm., Tokyo Univ. Sch. Pharm.)

Session information